SCHEMBL27868359

SCHEMBL27868359

NCC(=O)c1ccc(N)cc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.44
▸ KDM4E B2RXH2 6/20 0.44
▸ TDP1 Q9NUW8 6/20 0.44
▸ MAPT P10636 5/20 0.44
▸ CYP3A4 P08684 5/20 0.44
▸ GAA P10253 3/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ THRB P10828 3/20 0.44
▸ RECQL P46063 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ POLB P06746 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ APEX1 P27695 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ MCL1 Q07820 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ CASP1 P29466 4/20 0.39
▸ HPGD P15428 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9559750 0.82 HSP90AB1 (0.48) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL28524236 0.80 MAPT (0.41) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL11509832 0.80 ALDH1A1 (0.55) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL29105091 0.76 RAPGEF4 (0.45) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL715406 0.76 KDM4E (0.65) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL7409099 0.76 MAPT (0.48) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL8759303 0.75 ALDH1A1 (0.50) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL3181880 0.74 ALDH1A1 (0.47) ALDH1A1KDM4ETDP1MAPTCYP3A4
Ammonia Solution, Strong SCHEMBL6030557 0.74 KDM4E (0.63) ALDH1A1KDM4ETDP1MAPTCYP3A4
SCHEMBL6030346 0.74 KDM4E (0.63) ALDH1A1KDM4ETDP1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102459281-A Hepatitis c virus inhibitors BRISTOL MYERS SQUIBB CO 2012-05-16 — — CN disclosed
Send feedback